Wednesday, 23 January 2013

Double-blind Ampligen research

Rintatolimod produced objective improvement in ET [exercise tolerance] and a reduction in CFS/ME related concomitant medication usage as well as other secondary outcomes.

Read more

Pamela is a former accountant, recovering journalist and international cat herder, disabled and chronically sick with Myalgic Encephalomyelitis, Fibromyalgia and Cervical spondylosis, fluent in three languages; English, Spanish and Rubbish. Mostly writes in the latter. She likes Genealogy, Model Railways and Cats.

No comments:

Related Posts Plugin for WordPress, Blogger...
^ Top